MGB
TNGX icon

Mass General Brigham’s Tango Therapeutics TNGX Stock Holding History

Mass General Brigham’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1M Hold
354,192
– – 3.07% 4
2026
Q1 		$7.41M Hold
354,192
– – 1.58% 4
2025
Q4 		$3.14M Buy
+354,192
New +$3.05M 0.39% 5
2024
Q3 		$2.73M Hold
354,192
– – 6.25% 4
2024
Q2 		$3.04M Hold
354,192
– – 14.79% 3
2024
Q1 		$2.81M Buy
+354,192
New +$3.8M 4.92% 4

Other funds holding TNGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Mass General Brigham's TNGX Position: Q2 2026 in Review

Mass General Brigham held its Tango Therapeutics (TNGX) position steady in Q2 2026 at 354,192 shares worth $11.1M. The position accounts for 3.07% of the portfolio, ranked #4.

Mass General Brigham first reported a position in TNGX in Q1 2024 and has held it in 6 quarters since. 106 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Mass General Brigham held 354,192 shares of Tango Therapeutics worth $11.1M as of Q2 2026.
  • Mass General Brigham left its Tango Therapeutics share count unchanged in Q2 2026.
  • Tango Therapeutics made up 3.07% of Mass General Brigham's portfolio in Q2 2026, its #4 holding.
  • Mass General Brigham first reported a position in Tango Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • 106 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Mass General Brigham's 13F filing for Q2 2026, filed 7 Aug 2026.